	US 11,911,426 B2
	Use of a plant in preparation of medicines and health products for preventing and treating ovarian injury
Rui He, Ningxia (CN); Guangyong Li, Ningxia (CN); Puguang Yu, Ningxia (CN); Yang Niu, Ningxia (CN); and Huiming Ma, Ningxia (CN)
Assigned to Ningxia Medical University, Yinchua (CN)
Filed by Ningxia Medical University, Ningxia (CN)
Filed on Jun. 10, 2021, as Appl. No. 17/344,008.
Claims priority of application No. 202010524177.7 (CN), filed on Jun. 10, 2020; application No. 202010525295.X (CN), filed on Jun. 10, 2020; application No. 202010525304.5 (CN), filed on Jun. 10, 2020; and application No. 202010525333.1 (CN), filed on Jun. 10, 2020.
Prior Publication US 2021/0386810 A1, Dec. 16, 2021
Int. Cl. A61K 36/185 (2006.01); A61P 5/24 (2006.01); A61P 5/30 (2006.01); A61P 15/08 (2006.01)

CPC A61K 36/185 (2013.01) [A61P 5/24 (2018.01); A61P 5/30 (2018.01); A61P 15/08 (2018.01)]

4 Claims

1. A method for treating ovarian injury induced by chemoradiotherapy in a subject in need thereof, comprising administering to the subject an effective amount of a composition comprising fruit pulp or seed oil of Sea buckthorn (Hippophae rhamnoides Linn), or a combination thereof.